Study Reveals Transgenic Goats Can be Used to Produce Antibodies Against CancerJune 17, 2020
Scientists from AgResearch in New Zealand have developed transgenic goats that produce monoclonal antibodies or mAbs, a known candidate for anti-cancer therapy. With further research, the transgenic goats may prove to produce large volumes of the protein through their milk without the expensive production costs of the same protein in lab-controlled environments.
The scientists developed several transgenic goat lines that produced cetuximab in their milk. Cetuximab is a mAb used against the epidermal growth factor receptor and an approved anti-cancer treatment. The scientists inserted genes responsible for the production of mAb in the milk to the goat's genome cells. They then used cloning technology to grow the goats.
After selection, two promising lines exhibited stable genotypes and cetuximab production levels of up to 10g per liter. They observed that the mAb produced by the goats was fully functional, can be easily purified, and less immunogenic with improved characteristics compared to its commercially-produced counterpart. The study concluded that transgenic goats are efficient for large-scale production of therapeutic mAbs. With the exception of the change in their milk, they remain healthy and normal animals.
You might also like:
- GM Chickens Developed to Lay Anti-cancer Eggs
- Sheep Genome Decoded
- Thousands of Breast Cancer Gene Versions Classified Using CRISPR-Cas9
The Crop Biotech Update is a weekly newsletter of ISAAA, a not-for-profit organization. The CBU is distributed for free to over 23,000 subscribers worldwide to inform them about the key developments in biosciences, especially in agricultural biotechnology. Your support will help us in our mission to feed the world with knowledge. You can help by donating as little as $10.
See more articles:
- Scientists Find Super-potent Human Antibodies from Recovered COVID-19 Patients
News from Around the World
- Soil Health Trailblazer is 2020 World Food Prize Laureate
- Genome Editing 101: Healthcare and Industrial Applications and Regulations
- Australian OGTR Authorizes Clinical Trial of GM Influenza Vaccine
- World Experts Release Roadmap for Next Generation Crops
- Israeli Scientists Discover Possibilities of Plant-Sustained Electricity
- Study Reveals Transgenic Goats Can be Used to Produce Antibodies Against Cancer
- OsCpn60β1 Vital for Chloroplast Development in Rice, Study
Plant Breeding Innovations
- High-Efficiency Reduction of Rice Amylose Content via CRISPR-Cas9-Mediated Base Editing
- New Protocol: Genome Editing Using Rice Zygotes
Read the latest:
- Crop Biotech Update (August 10, 2022)
- Genome Editing Supplement (August 10, 2022)
- Gene Drive Supplement (July 27, 2022)
Subscribe to CBU: